ACP-204 for Alzheimer's Disease Psychosis Start: Nov. 14, 2023 End: February 2028

New and featured studies Click on the trial name for details and contact information. https://www.alzheimers.gov/clinical-trials/acp-204-alzheimers-disease-psychosis?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20240122 Sargramostim for Mild to Moderate Alzheimer's Disease Start: June 1, 2022 End: July 2024 https://www.alzheimers.gov/clinical-trials/sargramostim-mild-moderate-alzheimers-disease?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20240122